Consensus Centene Corporation

Stocks

CNC

US15135B1017

Managed Healthcare

Market Closed - NYSE 01:30:02 31/10/2026 am IST			5-day change	1st Jan Change
68.45 ^USD	-0.25%		-2.45%	+66.34%

28/10	UBS Adjusts Price Target on Centene to $78 From $70, Maintains Neutral Rating	MT
28/10	Centene: Profits Recover, but fewer Insured Clients

Evolution of the Average Target: Centene Corporation

Evolution of the Target Price: Centene Corporation

Changes in Analyst Recommendations: Centene Corporation

a0cc93b813dce1c2775a03c2428.WstfzLW4u2K9DF95TgfsrXyRo7LgsxUy5N5leeYxiZk.L6gRg9fRjCznZzo_OzKbwSX8_OCL33lDye4HIbdo_98MpCiv_-nfCshYKA~ab4165176e9f56b327fac6b2a10e71d7

Analysts' recommendations: Centene Corporation

28/10	UBS Adjusts Price Target on Centene to $78 From $70, Maintains Neutral Rating	MT
11/09	BofA Securities Adjusts Centene Price Target to $80 From $78	MT
11/08	Argus Research Upgrades Centene to Buy From Hold, $80 Price Target	MT
04/08	JPMorgan Adjusts Price Target on Centene to $67 From $60, Maintains Neutral Rating	MT
03/08	Bernstein Adjusts Centene Price Target to $79 From $68, Maintains Outperform Rating	MT
29/07	Centene's Strong Q2 Beat Overshadowed by Delayed Medicaid Margin Recovery, RBC Says	MT
29/07	UBS Adjusts Price Target on Centene to $70 From $61, Maintains Neutral Rating	MT
29/07	Jefferies & Co Adjusts Centene Price Target to $59 From $48, Maintains Hold Rating	MT
29/07	Truist Lifts Price Target on Centene to $80 From $78, Keeps Buy Rating	MT
29/07	Goldman Sachs Adjusts Centene Price Target to $56 From $40, Maintains Sell Rating	MT
29/07	Morgan Stanley Adjusts Centene Price Target to $66 From $57, Maintains Equal Weight Rating	MT
29/07	Baird Adjusts Centene Price Target to $66 From $46, Maintains Neutral Rating	MT
29/07	Deutsche Bank Adjusts Centene Price Target to $85 From $80, Maintains Buy Rating	MT
29/07	Analyst recommendations: Carmax, Kla Corporation, Nasdaq, Fortinet, PayPal…
28/07	Barclays Raises Centene Price Target to $80 From $75	MT
14/07	Truist Raises Price Target on Centene to $78 From $71, Keeps Buy Rating	MT
14/07	TD Cowen Adjusts Price Target on Centene to $65 From $47, Maintains Hold Rating	MT
13/07	Mizuho Adjusts Price Target on Centene to $69 From $63, Maintains Neutral Rating	MT
13/07	Wells Fargo Adjusts Price Target on Centene to $69 From $56, Maintains Equalweight Rating	MT
09/07	RBC Trims Price Target on Centene to $71 From $70, Maintains Sector Perform Rating	MT
07/07	Cantor Fitzgerald Adjusts Centene Price Target to $75 From $60	MT
23/06	Centene's Multi-Year Recovery Underway, RBC Says	MT
23/06	RBC Initiates Centene at Sector Perform With $70 Price Target	MT
08/06	JPMorgan Adjusts Price Target on Centene to $60 From $52, Maintains Neutral Rating	MT
04/06	UnitedHealth, CVS, Cigna Seen Benefiting From Utilization Trends, AI Upside, Morgan Stanley Says	MT

More recommendations

Other Managed Healthcare

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	CENTENE CORPORATION					+8.84%
	UNITEDHEALTH GROUP INC.					+17.12%
	ELEVANCE HEALTH, INC.					+14.83%
	CIGNA					+14.77%
	HUMANA INC.					+12.21%
	MOLINA HEALTHCARE, INC.					+7.2%
	BRADSAÚDE S.A.					+28.81%
	CLOVER HEALTH INVESTMENTS, CORP.					+23.32%
	PROGYNY, INC.					+17.91%
	ALIGNMENT HEALTHCARE, INC.					+50.73%
	Average					+19.58%
	Weighted average by Cap.					+15.77%